Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0J9UB
|
||||
Former ID |
DNCL002463
|
||||
Drug Name |
RG7593
|
||||
Indication | Hematological malignancies [ICD9: 200-209; ICD10:C81-C86] | Discontinued in Phase 2 | [548683] | ||
Company |
Seattle Genetics; Roche
|
||||
Target and Pathway | |||||
Target(s) | B-cell receptor CD22 | Target Info | Modulator | [551601] | |
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
WikiPathways | B Cell Receptor Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.